Adjuvant Quil A improves protection in mice and enhances opsonic capacity of antisera induced by pneumococcal polysaccharide conjugate vaccines
- 31 December 1994
- Vol. 12 (15) , 1419-1422
- https://doi.org/10.1016/0264-410x(94)90151-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgGInfection and Immunity, 1994
- Adjuvants — a balance between toxicity and adjuvanticityVaccine, 1993
- Protein-conjugated synthetic di- and trisaccharides of pneumococcal type 17F exhibit a different immunogenicity and antigenicity than tetrasaccharideVaccine, 1993
- The influence of the adjuvant quil a on the epitope specificity of meningococcal lipopolysaccharide anti-carbohydrate antibodiesMolecular Immunology, 1991
- Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3,7,9 phosphoethanolamine group-containing oligosaccharide-protein conjugatesInfection and Immunity, 1991
- Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex.The Journal of Immunology, 1991
- Natural and Vaccine-Related Immunity to Streptococcus pneumoniaeThe Journal of Infectious Diseases, 1986
- A sensitive protein assay method using micro-titer platesCellular and Molecular Life Sciences, 1986
- Phagocytosis and cytolysis by a macrophage tumour and its cloned cell lineNature, 1975
- Colorimetric Method for Determination of Sugars and Related SubstancesAnalytical Chemistry, 1956